drugset / Trial / NCT02033707

Effects of Hallucinogens and Other Drugs on Mood and Performance

NCT02033707

Phase 1 Completed 20 enrolled Johns Hopkins University
RandomizedParallel-groupTriple-blindBasic science

Summary

This non-treatment study will investigate the effects on mood and performance caused by hallucinogens and other psychoactive compounds.

Timeline

Start
2014-04
Primary completion
2019-02
Completion
2019-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextromethorphan Unknown 400 mg Oral
Subject Psilocybin Other / unclassified 10 mg Oral
Subject Psilocybin Other / unclassified 20 mg Oral
Subject Psilocybin Other / unclassified 30 mg Oral
Background 4-phosphoryloloxy-N-diethyltryptamine Unknown
Background Alcohol Other / unclassified
Background Alprazolam Small molecule
Background Caffeine Small molecule
Background Cannabis Traditional medicine (herbal / TCM)
Background Chlorpheniramine Unknown
Background Codeine Small molecule
Background DMT Unknown
Background Dextroamphetamine Small molecule
Background Diacetylmorphine Small molecule
Background Diazepam Small molecule
Background Diphenhydramine Unknown
Background Ephedrine Small molecule
Background Hydrocodone Unknown
Background Ketamine Small molecule
Background LSD Unknown
Background Lorazepam Small molecule
Background MDMA Unknown
Background Mescaline Small molecule
Background Methadone Other / unclassified
Background Methylphenidate Small molecule
Background Morphine Other / unclassified
Background Nicotine Unknown
Background Oxycodone Other / unclassified
Background PCP Unknown
Background Salvinorin A Small molecule
Background Scopolamine Unknown
Background Temazepam Small molecule
Background Triazolam Small molecule
Background Zolpidem Small molecule
Background d-lysergic acid amide (LSA) Unknown
Background diethylproprion Unknown
Background dipropyltryptamine (DPT) Unknown
Background secobarbital Small molecule

Indications

No indication recorded.